Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Clinical Therapeutics
|
April 11, 2001
Economic implications of early treatment of migraine with sumatriptan tablets
R K Cady, F Sheftell, R B Lipton, et al.
Lipids
|
February 1, 1978
Inhibition of diacylglycerol:CDPcholine cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetate
S Parthasarathy, R K Cady, D S Kraushaar, et al.
Headache
|
January 3, 2001
Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study
R K Cady, R B Lipton, C Hall, et al.
The Journal of Family Practice
|
January 1, 1996
Improvements in health-related quality of life with sumatriptan treatment for migraine
P Jhingran, R K Cady, J Rubino, et al.
Neurology
|
July 1, 1993
Efficacy of subcutaneous sumatriptan in repeated episodes of migraine
R K Cady, J Dexter, J D Sargent, et al.
Clinical Therapeutics
|
July 1, 1996
Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System
G R Mushet, R K Cady, C C Baker, et al.
JAMA
|
June 15, 1991
Treatment of acute migraine with subcutaneous sumatriptan
R K Cady, J K Wendt, J R Kirchner, et al.
Neurology
|
December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group
G D Solomon, R K Cady, J A Klapper, et al.
Mayo Clinic Proceedings
|
August 16, 2000
Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial
E A Schulman, R K Cady, D Henry, et al.
Clinical Therapeutics
|
October 26, 2000
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials
R K Cady, F Sheftell, R B Lipton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Clinical Therapeutics
|
April 11, 2001
Economic implications of early treatment of migraine with sumatriptan tablets
R K Cady, F Sheftell, R B Lipton, et al.
Lipids
|
February 1, 1978
Inhibition of diacylglycerol:CDPcholine cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetate
S Parthasarathy, R K Cady, D S Kraushaar, et al.
Headache
|
January 3, 2001
Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study
R K Cady, R B Lipton, C Hall, et al.
The Journal of Family Practice
|
January 1, 1996
Improvements in health-related quality of life with sumatriptan treatment for migraine
P Jhingran, R K Cady, J Rubino, et al.
Neurology
|
July 1, 1993
Efficacy of subcutaneous sumatriptan in repeated episodes of migraine
R K Cady, J Dexter, J D Sargent, et al.
Clinical Therapeutics
|
July 1, 1996
Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System
G R Mushet, R K Cady, C C Baker, et al.
JAMA
|
June 15, 1991
Treatment of acute migraine with subcutaneous sumatriptan
R K Cady, J K Wendt, J R Kirchner, et al.
Neurology
|
December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group
G D Solomon, R K Cady, J A Klapper, et al.
Mayo Clinic Proceedings
|
August 16, 2000
Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial
E A Schulman, R K Cady, D Henry, et al.
Clinical Therapeutics
|
October 26, 2000
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials
R K Cady, F Sheftell, R B Lipton, et al.
Page
of 3